- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| MEDICUS PHARMA Aktie jetzt für 0€ handeln | |||||
| Mo | Medicus Pharma Ltd. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.07. | Medicus Pharma Ltd. Announces Submission of Type C Meeting Request to the Food and Drug Administration (FDA) | 209 | Newsfile | Philadelphia, Pennsylvania--(Newsfile Corp. - July 8, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is pleased to announce submission of a comprehensive package to the United... ► Artikel lesen | |
| 04.07. | Medicus Pharma: Pflaster gegen Hautkrebs - ein Investment wert? | 529 | sharedeals.de | Eine hierzulande wohl ziemlich unbekannte Aktie ist die von Medicus Pharma. Das Unternehmen aus Kanada ist seit Ende letzten Jahres auch an der US-Nasdaq gelistet und hat Großes vor. Wenn der Plan aufgeht... ► Artikel lesen | |
| 30.06. | Medicus Pharma Ltd. - 8-K, Current Report | - | SEC Filings | ||
| 30.06. | Medicus Pharma to acquire Antev | 5 | Seeking Alpha | ||
| 30.06. | Medicus Pharma Ltd.: Medicus Pharma Ltd Announces a Definitive Agreement to Acquire Antev Ltd. UK | 275 | Newsfile | Philadelphia, Pennsylvania--(Newsfile Corp. - June 30, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus") and Antev Ltd. ("Antev"), a UK-based clinical-stage drug development company, announced... ► Artikel lesen | |
| 30.06. | XFRA DELETION OF INSTRUMENTS FROM XETRA - 30.06.2025 | 109 | Xetra Newsboard | The following instruments on XETRA do have their last trading day on 30.06.2025Die folgenden Instrumente in XETRA haben ihren letzten Handelstag am 30.06.2025ISIN NameCA58471K2020 MEDICUS PHARMA LTD.DE000HLB5782... ► Artikel lesen | |
| 23.06. | Medicus Pharma appoints Andrew Smith as chief operating officer | 2 | Investing.com | ||
| 23.06. | Medicus Pharma ernennt Andrew Smith zum Chief Operating Officer | 2 | Investing.com Deutsch | ||
| 23.06. | Medicus Pharma Ltd. Announces Appointment of Andrew Smith as Chief Operating Officer | 230 | Newsfile | Philadelphia, Pennsylvania--(Newsfile Corp. - June 23, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is pleased to announce the appointment of Andrew Smith as Chief Operating... ► Artikel lesen | |
| 20.06. | Medicus Pharma Ltd. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.06. | Medicus Pharma Ltd. to Present at 2025 Bio International Convention | 236 | Newsfile | Philadelphia, Pennsylvania--(Newsfile Corp. - June 12, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is pleased to announce the schedule of the presentation of Dr. Raza Bokhari... ► Artikel lesen | |
| 09.06. | Medicus Pharma advances cancer patch for horses | 2 | Investing.com | ||
| 09.06. | Medicus Pharma Ltd. Announces Submission of Product Development Plan to the Food and Drug Administration (FDA) to Treat External Squamous Cell Carcinoma (SCC) in Horses | 232 | Newsfile | Philadelphia, Pennsylvania--(Newsfile Corp. - June 9, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is pleased to announce submission of a comprehensive product development... ► Artikel lesen | |
| 02.06. | Medicus Pharma Ltd. - 8-K, Current Report | - | SEC Filings | ||
| 02.06. | Medicus Pharma schließt öffentliches Angebot über 7 Millionen US-Dollar ab | 7 | Investing.com Deutsch | ||
| 02.06. | Medicus Pharma completes $7 million public offering | 1 | Investing.com | ||
| 02.06. | Medicus Pharma Ltd. Announces Closing of $7.0 Million Public Offering | 302 | Newsfile | Philadelphia, Pennsylvania--(Newsfile Corp. - June 2, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) (the "Company") today announced the closing of its previously announced public offering of 2,260,000... ► Artikel lesen | |
| 30.05. | Pre-market Movers: Bolt Projects, Basel Medical Group, Red Robin Gourmet Burgers, LZ Technology, Medicus Pharma | 904 | AFX News | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 06.55 A.M. ET).In the Green Bolt Projects Holdings, Inc. (BSLK) is up over 114%... ► Artikel lesen | |
| 30.05. | Medicus Pharma prices $7 million share offering | 1 | Seeking Alpha |
1 2 3 4 Weiter >>
70 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PFIZER | 21,150 | -0,26 % | Wie BioNTech, PanGenomic Health und Pfizer mit Künstlicher Intelligenz Kosten sparen und ihre Rendite boosten | Die Digitalisierung revolutioniert die Biotechnologie- und Pharmabranche. Künstliche Intelligenz durchforstet Milliarden medizinischer Daten in Echtzeit und beschleunigt die Medikamentenentwicklung... ► Artikel lesen | |
| GILEAD SCIENCES | 94,39 | +0,44 % | Gilead Sciences-Aktie verliert 4,36 Prozent (93,65 €) | Am US-amerikanischen Aktienmarkt liegt das Wertpapier von Gilead Sciences zur Stunde im Minus. Das Papier kostete zuletzt 93,65 Euro. Die Aktie von Gilead Sciences verzeichnet derzeit einen Abschlag... ► Artikel lesen | |
| VERTEX PHARMACEUTICALS | 399,30 | -0,65 % | Vertex Pharmaceuticals Incorporated: Vertex Announces Broad Reimbursement Agreement With NHS England for ALYFTREK (Deutivacaftor/Tezacaftor/Vanzacaftor) an Innovative Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis | All eligible people with CF in England can now benefit from this medicine - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that it has reached a broad reimbursement agreement... ► Artikel lesen | |
| EYEPOINT PHARMACEUTICALS | 8,594 | +1,20 % | EyePoint Pharmaceuticals, Inc.: EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | WATERTOWN, Mass., July 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients... ► Artikel lesen | |
| ROCKET LAB | 41,000 | +6,22 % | Neu: SpaceX bei Robinhood - Rocket Lab im Depot 2030 | Raumfahrt-Boom an der Börse. Visionen von Robotern auf dem Mars und neue Defense-Anwendungen sorgen für enormen Aufwind. SpaceX-Rivale Rocket Lab ist seit Kauf im Juni 2025 nun 55 Prozent im Depot 2030... ► Artikel lesen | |
| ASTRIA THERAPEUTICS | 5,450 | 0,00 % | Astria Therapeutics, Inc.: Astria Therapeutics Announces Positive Initial Results from the ALPHA-SOLAR Long-Term Open-Label Trial of Navenibart in Hereditary Angioedema Patients at the European Academy of Allergy and Clinical Immunology Annual Congress | -- Q3M Arm Demonstrated 95% Mean Monthly Attack-Rate Reduction -- -- Q6M Arm Demonstrated 86% Mean Monthly Attack-Rate Reduction - -- Well-Tolerated with a Favorable Safety Profile -- --... ► Artikel lesen | |
| OPKO HEALTH | 1,121 | +2,24 % | OPKO Health, Inc.: OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting | MIAMI and JERUSALEM, June 25, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) and Entera Bio Ltd. (NASDAQ: ENTX) ("Entera") today announced that new pharmacologic and pharmacokinetic in vivo... ► Artikel lesen | |
| LIGAND PHARMACEUTICALS | 106,00 | -1,85 % | Ligand Pharma Earns Milestone Payment From Pelthos On Commercial Launch Of ZELSUVMI | WASHINGTON (dpa-AFX) - Ligand Pharmaceuticals (LGND) announced that its partner Pelthos Therapeutics Inc. (PTHS) has commercially launched ZELSUVMI or berdazimer topical gel 10.3%, the first... ► Artikel lesen | |
| JAZZ PHARMACEUTICALS | 98,08 | +1,30 % | Jazz Pharmaceuticals plc: Jazz Pharmaceuticals Names Renee Gala as President and Chief Executive Officer | - Selection Follows Robust Succession Process Led by the Board -
- Bruce Cozadd to Retire as CEO and Remain Chairperson of the Board of Directors -
DUBLIN, July 10, 2025 /PRNewswire/... ► Artikel lesen | |
| ROYALTY PHARMA | 30,670 | -2,54 % | Revolution Medicines, Inc.: Revolution Medicines Enters Into $2 Billion Flexible Funding Agreement with Royalty Pharma to Support Global Development and Commercialization of RAS(ON) Inhibitor Portfolio for Patients with ... | Flexible funding provides $2 billion in committed capital comprised of up to $1.25 billion of synthetic royalty and up to $750 million in corporate debtCompany moving forward with independent global... ► Artikel lesen | |
| CATALYST PHARMACEUTICALS | 18,140 | +0,47 % | Catalyst Pharma: Viel Wachstum für wenig Geld? | Die meisten Biotech-Aktien sind vor allem eins: hochspekulativ. Catalyst Pharma beweist jedoch, dass es auch anders geht - mit realen Gewinnen und nachhaltigem Wachstum Den vollständigen Artikel lesen... ► Artikel lesen | |
| TG THERAPEUTICS | 34,220 | +4,57 % | Goldman Sachs nimmt Bewertung von TG Therapeutics mit "Neutral" wieder auf | ||
| CORBUS PHARMACEUTICALS | 7,200 | +3,60 % | Corbus Pharmaceuticals Holdings, Inc.: Corbus Pharmaceuticals Initiates Multiple Ascending Dose Portion of Phase 1 Study of Highly Peripherally Restricted CB1 Inverse Agonist CRB-913 for the Treatment of Obesity | No treatment-related neuropsychiatric events seen to date in SAD portion of Phase 1MAD study on track for completion in Q3 2025 NORWOOD, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals... ► Artikel lesen | |
| CATALENT | 59,93 | 0,00 % | GenSight Biologics Announces Significant Milestone in New Manufacturing Partnership with Catalent | Upstream phase of LUMEVOQ manufacturing process successfully transferred
Milestone follows successful manufacture of drug product batch to be used for named early access program (AAC) and... ► Artikel lesen | |
| TALPHERA | 0,396 | +9,56 % | Talphera, Inc.: Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update | Cash and investments at March 31, 2025, as adjusted to include the proceeds from the first tranche of the private placement financing which closed on April 2, 2025... ► Artikel lesen |
MEDICUS PHARMA LTD gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von +0,090 (+3,01 %) liegt der Kurs bei 3,080 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MEDICUS PHARMA LTD finden Sie auf Wallstreet Online.